April 30, 2018 07:54 AM EDTUpdated 08:14 AM
People

Who’s the top earn­ing CEO in bio­phar­ma? Mar­tine Roth­blatt once again hits top slot with $37M pay pack­age

John Carroll

Editor & Founder

For­get Al­ler­gan CEO Brent Saun­ders’ hefty $33 mil­lion pay pack­age for 2017. Ian Read, you and your $28 mil­lion Pfiz­er deal, com­plete with $1 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Kevin Tang's Con­cen­tra tries to dis­rupt pro­posed Ace­lyrin-Alu­mis merg­er

Pfiz­er ends roll­out of Be­qvez, putting an­oth­er dent in he­mo­phil­ia gene ther­a­py field

Mer­ck KGaA tees up changes to lead­er­ship team; Ex-CVS Health CEO joins Ther­mo Fish­er’s board

Roche no longer wants to be where ‘DNA se­quenc­ing goes to die’

Trump’s HHS de­fends drug price ne­go­ti­a­tions in No­var­tis suit

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times